Skip to main content
. 2017 Aug;13(3):244–250. doi: 10.2174/1573403X13666170510115628

Table 1.

Summary of all the animal studies in to the pathogenesis of PAVMs from 2000 to 2013.

Study Animal model SVC blood IVC blood Analysis Candidate molecule Results Mechanism of PAVM
Malhotra 2001 Lamb
N=24
RPA RA-RV-LPA Tissue mRNA expression
Blood from RPA
ACE
Angiotensin II
Reversible decreased ACE activity in lung Enzyme involved in angiogenesis inhibition
Malhotra 2002 Sheep Tissue Angiotensin receptors Increased type 1, 2 angiotensin receptors Pathological vascular remodeling
Malhotra 2002 Lamb
N=6
HIF Upregulation of HO1, GLUT1 Oxidative stress
Starnes 2002 Rat
N=8
Tissue microscopy
Immunohistochemistry
Nil Time dependent increase in micro-vessel density in the shunted lung Angiogenesis
Ikai 2004 Lamb
N=6
RA-RV-LPA
LPA band
Tissue-lung
Western blot,
Immunostaining
HGF
Cmet
Bcl2
C-met expression increased in lung Growth factor in angiogenesis
anti-apoptotic
Ikai 2004 Rabbit RA-RV-LPA Tissue HIF1α Lack of hypoxic pulmonary vasoconstriction Oxidative stress
Mumtaz 2004 Rat
N-=3
RA-RV-LPA Tissue mRNA expression VEGF Progressive increase in VEGF mRNA Final pathway VEGF
Ikai 2005 Rabbit RPA/ PA band RA-RV-LPA Tissue Nil Even partial maintenance of right lung blood supply (from hepatic vein) maintains hypoxic pulmonary vasoconstriction Oxidative stress
McMullan 2008 Lamb
N=23
RPA RA-RV-LPA Tissue morphology Nil Morphology of PAVMs
Kavarana 2013 Porcine
N=5
RPA RA-RV-LPA Tissue gene expression Angiopoietin1
TIE2
(Angiopoietin receptor)
Angiostatin
Conversion of PAEC to a proangiogenic phenotype
Increased proliferation and tubule formation
Angiogenesis
HIF Gene expression not different
Henaine 2013 Porcine
N=10
RPA/PA band RA-RV-LPA Tissue Pulsatile flow PAVMs, Increased PAP, PVR in non-pulsatile > micro-pulsatile > pulsatile Antegrade pulsatile flow prevents PAVMs

Note. 11 studies using Rabbit, Lamb, pigs and rats. SVC blood connected to RPA and IVC blood from IVC to RA to LPA after banding or disconnecting the RPA. Looked for blood or tissue for ACE, Angiotensin, HGF, HIF, VEGF, Angiopoietin, angiopoietin receptor or angiostatin or to define the pulsatility of pulmonary blood flow. There is evidence of angiogenesis in the lungs, ACE is involved in inhibition of angiogenesis, and the final pathway for PAVMs is through VEGF evidenced by progressive increase in VEGF mRNA [19-30].